Affiliation:
1. Wollongong Hospital
2. University of Kelaniya
Abstract
Abstract
Background
Pre-operative long-course chemoradiotherapy (CRT) for rectal cancer has resulted in improvement in rates of restorative rectal resection and local recurrence by inducing tumour downstaging and down-sizing. Total mesorectal excision (TME) is a standardised surgical technique of low anterior resection aimed at prevention of local tumour recurrence. The purpose of this study was to evaluate tumour response following CRT in a standardised group of patients with rectal cancer.
Methods
One hundred and thirty-one patients (79 male; 52 female, median age 57; interquartile range 47 – 62 years) with rectal cancer underwent pre-operative long-course CRT followed by standardised open low anterior resection at a median of 10weeks post-CRT. Median follow up at the time of analysis was 15 months (interquartile range 6 – 45 months). Pathology reports were analysed based on AJCC-UICC classification using the TNM system. Data recorded were overall/sub-grades of tumour regression; good, moderate or poor, lymph node harvest, local recurrence, disease-free and overall survival using standard statistical methods.
Results
Seventy eight percent showed tumour regression post CRT; 43% displayed good tumour regression/response while 22% had poor tumour regression/response. All patients had a pre-operative T-stage of either T3 or T4. Post-operation, those classified as good responders had a median T stage of T2 vs. T3 in poor responders (P=0.0002). Overall, median lymph node harvest was less than 12. There was no difference in the number of nodes harvested in good responders vs. poor responders (Good/moderate-6 nodes vs. Poor- 8; P=0.31). Good responders tended to have a lesser number of malignant nodes vs. poor responders (P=0.31). Overall, local recurrence was 6.8% and there was no significant difference in predicted 5-year disease-free or overall survival between good and poor responders.
Conclusion
The use of pre-operative long-course CRT results in satisfactory tumour regression and enables consideration for safe, sphincter resection in rectal cancer. A dedicated multi-disciplinary team approach achieved a global benchmark for local recurrence. Further research will be aimed at methods to improve overall lymph node harvest in irradiated patients with rectal cancer having low anterior resection.
Publisher
Research Square Platform LLC
Reference23 articles.
1. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer R;J Clin Oncol,2012
2. Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis;Kasi A;JAMA Netw Open,2020
3. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711-7; discussion 7–8.
4. Management of rectal cancer: the 2016 French guidelines;Lakkis Z;Colorectal Dis,2017
5. Comparison of guidelines for the management of rectal cancer;Luzietti E;BJS Open,2018